Gold prices dip as December rate cut bets wane; economic data in focus
Investing.com - Citizens has reiterated its Market Outperform rating and $75.00 price target on Xometry Inc (NASDAQ:XMTR) following meetings with the company’s CFO James Miln and VP of IR Shawn Milne last week. The target represents about 24% upside from the current price of $60.58, though InvestingPro data suggests the stock is trading above its Fair Value.
The firm highlighted several catalysts for Xometry , including the ramp of injection molding following the launch of instant quote functionality, continued international growth, and expected resumption of growth at Thomasnet. These growth initiatives align with the company’s impressive 22.4% revenue growth over the last twelve months, with analysts forecasting 24% revenue growth for the current fiscal year.
Citizens noted qualitative improvements in Xometry’s leadership team, specifically mentioning that President Sanjeev Sahni is helping attract higher-quality talent, particularly to the company’s new Boston office, which has led to an accelerated product release cadence. While the company isn’t currently profitable, InvestingPro data shows analysts expect Xometry to turn profitable this year with forecasted earnings of $0.36 per share.
The research firm observed significant business momentum for Xometry in the $2 trillion custom manufacturing market, stating the company offers "a better experience when purchasing custom parts with growing network effects and data moats."
Citizens maintained its unchanged $75 price target on Xometry stock, expressing confidence the company may have "already reached an exit velocity" in its market.
In other recent news, Xometry Inc reported its third-quarter 2025 earnings, surpassing Wall Street expectations. The company achieved an earnings per share (EPS) of $0.11, compared to the forecasted $0.10, and reported revenue of $180.71 million, exceeding the anticipated $168.25 million. Following this strong performance, Xometry has raised its fourth-quarter growth outlook from 20-21% to 25-27%. Analysts have responded positively to these developments, with JPMorgan raising its price target for Xometry to $70, citing the company’s strong third-quarter performance and accelerated marketplace revenue growth. Goldman Sachs also increased its price target to $56, highlighting Xometry’s robust marketplace performance and the growing impact of digital transformation. Cantor Fitzgerald adjusted its price target to $60, acknowledging the company’s record quarterly revenue, gross profit, and adjusted EBITDA. These analyst updates reflect a favorable view of Xometry’s recent achievements and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.